Tumor News and Research

RSS

Researchers develop an integrated technology for seeing into cells at greater detail

Invading cells' private space - prying into their internal functions, decisions and communications - could be a powerful tool that may help researchers develop new immunotherapy treatment for cancer.

12 Aug 2020

More than 40-year-old cancer mystery solved: Thanks to epigenetics

In an article that was just published in Proceedings of the National Academy of Sciences by the group of Dr. Manel Esteller, is solved this mystery by describing that in cancer cells the protein that generates the nucleotide "Y" is epigenetically inactivated, causing small but highly aggressive tumors.

12 Aug 2020

SPT enzyme can be used as metabolically responsive “switch” to slow tumor growth

The enzyme serine palmitoyl-transferase can be used as a metabolically responsive "switch" that decreases tumor growth, according to a new study by a team of San Diego scientists, who published their findings Aug. 12 in the journal Nature.

12 Aug 2020

Researchers develop novel approach for utilizing 4D-printing of arrays to accelerate drug testing

Investigators at Rutgers Cancer Institute of New Jersey have developed a novel approach for utilizing 4-dimensional (4D) printing of arrays that transform from cell-culture inserts into histological cassettes that hold patient tissue samples for rapid programmable drug testing.

12 Aug 2020

Researchers review scientific articles on proteins that help cancer cells enter the brain

An international team of scientists, including a researcher from Sechenov University, reviewed scientific articles on proteins (and genes encoding them) that help cancer cells enter the brain.

12 Aug 2020

Simple process could enhance personalization of cancer therapy

Researchers have developed a simplified process that could enhance personalization of cancer therapy based on a single nuclear medicine scan.

12 Aug 2020

COMBAT study shows how pancreatic cancer patients can benefit from immunotherapy

Working with an international team of researchers, HonorHealth Research Institute and the Translational Genomics Research Institute, an affiliate of City of Hope, were instrumental in one of the first clinical trials showing how pancreatic cancer patients can benefit from immunotherapy, according to a four-year study published in a premier scientific journal, Nature Medicine.

11 Aug 2020

Mouse study shows potential new way to unlock the power of immunotherapy for cancer patients

Immunotherapy has revolutionized cancer treatment by stimulating the patient's own immune system to attack cancer cells, yielding remarkably quick and complete remission in some cases. But such drugs work for less than a quarter of patients because tumors are notoriously adept at evading immune assault.

11 Aug 2020

First clinical trial could become an effective way to deliver chemotherapy to abdominal cancer patients

City of Hope surgical researchers are the first in the nation to open a clinical trial that could one day become an effective way to deliver chemotherapy to abdominal cancer patients who currently have very few treatment options.

11 Aug 2020

Researchers discover dose threshold that improves delivery of cancer-fighting drugs into a tumor

University of Toronto Engineering researchers have discovered a dose threshold that greatly increases the delivery of cancer-fighting drugs into a tumor.

11 Aug 2020

Oxygen-deprived breast cancer cells send out messages that promote cancer progression

According to a study by The Wistar Institute, breast cancer cells starved for oxygen send out messages that induce oncogenic changes in surrounding normal epithelial cells.

11 Aug 2020

TAU researchers reduce colorectal cancer metastases after tumor removal surgery

A research group from Tel Aviv University successfully reduced metastatic spread following tumor removal surgery in colorectal cancer patients.

10 Aug 2020

COVID-19 patient with repeatedly undetectable SARS-CoV-2 antibodies

A recent case study published in the Journal of Applied Laboratory Medicine in August 2020 illustrates this with its finding of persistent seronegativity in a patient confirmed to be SARS-CoV-2 positive.

10 Aug 2020

UT Southwestern physicians eliminate sociodemographic disparities in testicular cancer patients

By offering the same level of care and expertise to two very different populations, UT Southwestern physicians were able to eliminate the sociodemographic disparities in survival and cancer recurrence rates typically seen nationally in testicular cancer patients.

10 Aug 2020

FDA approves first companion diagnostic that uses liquid biopsy and NGS technology

Today, the U.S. Food and Drug Administration approved the first liquid biopsy companion diagnostic that also uses next-generation sequencing (NGS) technology to identify patients with specific types of mutations of the epidermal growth factor receptor (EGFR) gene in a deadly form of metastatic non-small cell lung cancer (NSCLC).

7 Aug 2020

UTHSC professor recognized for contributions to pioneering cancer genomic research

Neil Hayes, MD, MS, MPH, division chief of Hematology and Oncology at the University of Tennessee Health Science Center, is among recipients of the 2020 Team Science Awards from the American Association for Cancer Research for his contributions to developing The Cancer Genome Atlas, a groundbreaking multisite project to understand cancer at its molecular level through genome sequencing and extensive data analysis.

7 Aug 2020

Tumor News and Research

Researchers develop an integrated technology for seeing into cells at greater detail

More than 40-year-old cancer mystery solved: Thanks to epigenetics

SPT enzyme can be used as metabolically responsive “switch” to slow tumor growth

Researchers develop novel approach for utilizing 4D-printing of arrays to accelerate drug testing

Researchers review scientific articles on proteins that help cancer cells enter the brain

Simple process could enhance personalization of cancer therapy

COMBAT study shows how pancreatic cancer patients can benefit from immunotherapy

Mouse study shows potential new way to unlock the power of immunotherapy for cancer patients

First clinical trial could become an effective way to deliver chemotherapy to abdominal cancer patients

Researchers discover dose threshold that improves delivery of cancer-fighting drugs into a tumor

Oxygen-deprived breast cancer cells send out messages that promote cancer progression

TAU researchers reduce colorectal cancer metastases after tumor removal surgery

COVID-19 patient with repeatedly undetectable SARS-CoV-2 antibodies

UT Southwestern physicians eliminate sociodemographic disparities in testicular cancer patients

FDA approves first companion diagnostic that uses liquid biopsy and NGS technology

UTHSC professor recognized for contributions to pioneering cancer genomic research

Method provides new insight into brain cells that maintain body's master circadian clock.

Nanomedicine-based strategy enhances anti-PD1 therapy to eradicate PTEN-negative GBM

Researchers use patient-specific tumor organoid to optimize chemotherapy for appendix, colon tumors

An 'intelligent' strategy for real-time evaluation of photothermal therapy efficiency on tumors

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News